JL
Joon Lee Truist Securities Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Vertex Pharmaceuticals
VRTX
$102B
| $396.12 | $490 |
24%
upside
| Buy | 1 month ago |
|
2 |
2
PTC Therapeutics
PTCT
$4.55B
| $57.26 | $86 |
50%
upside
| Buy | 1 month ago |
|
3 |
3
Viking Therapeutics
VKTX
$3.03B
| $26.98 | $75 |
178%
upside
| Buy | 4 months ago |
|
4 |
4
Arvinas
ARVN
$575M
| $7.83 | $21 |
168%
upside
| Buy | 5 months ago |
|
5 |
5
Corcept Therapeutics
CORT
$7.31B
| $69.36 | $150 |
116%
upside
| Buy | 5 months ago |
|
6 |
6
Intellia Therapeutics
NTLA
$1.29B
| $12.06 | $50 |
315%
upside
| Buy | 6 months ago |
|
7 |
7
Praxis Precision Medicines
PRAX
$986M
| $46.85 | $85 |
81%
upside
| Buy | 6 months ago |
|
8 |
8
Axsome Therapeutics
AXSM
$6.25B
| $125.17 | $200 |
60%
upside
| Buy | 6 months ago |
|
9 |
9
CRISPR Therapeutics
CRSP
$4.99B
| $54.86 | $120 |
119%
upside
| Buy | 6 months ago |
|
10 |
10
Larimar Therapeutics
LRMR
$337M
| $3.94 | $18 |
357%
upside
| Buy | 7 months ago |
|
11 |
11
argenx
ARGX
$45.9B
| $750.78 | $700 |
7%
downside
| Buy | 7 months ago |
|
12 |
VRNA
12
Verona Pharma
VRNA
$9.2B
| $106.31 | $57 |
46%
downside
| Buy | 8 months ago |
|
13 |
13
Solid Biosciences
SLDB
$428M
| $5.50 | $16 |
191%
upside
| Buy | 8 months ago |
|
14 |
14
Wave Life Sciences
WVE
$1.32B
| $8.29 | $36 |
334%
upside
| Buy | 9 months ago |
|
15 |
15
Catalyst Pharmaceutical
CPRX
$2.48B
| $20.29 | $36 |
77%
upside
| Buy | 9 months ago |
|
16 |
16
CorMedix
CRMD
$926M
| $12.40 | $17 |
37%
upside
| Buy | 10 months ago |
|
17 |
17
BioMarin Pharmaceuticals
BMRN
$11.1B
| $57.77 | $90 |
56%
upside
| Buy | 11 months ago |
|
18 |
18
Jazz Pharmaceuticals
JAZZ
$7.86B
| $129.50 | $200 |
54%
upside
| Buy | 1 year ago |
|
19 |
19
Taysha Gene Therapies
TSHA
$917M
| $3.36 | $5 |
49%
upside
| Buy | 1 year ago |
|
20 |
20
AnaptysBio
ANAB
$613M
| $21.90 | $34 |
55%
upside
| Buy | 4 years ago |
|
21 |
21
CRISPR Therapeutics
CRSP
$4.99B
| $54.86 | $140 |
155%
upside
| Buy | 5 years ago |
|